Targeting Cancer Drugs to 3D-Printed Tumors

Targeting Cancer Drugs to 3D-Printed Tumors

The Corr lab at RPI and their collaborators at Albany Medical Center were featured by the American Society of Mechanical Engineering for their work in developing 3D bioprinting and imaging techniques designed to generate and analyze tumor models outside the body.... β€œTo achieve that, we have to not only develop new 3D bioprinting techniques to generate tumor models with prescribed cell composition and architecture, but also new imaging techniques to visualize how different drugs interact with cancer cells depending on where they are located within these tumor models.”

Researchers awarded $3.7M Grant: Advancing Personalized Anti-Cancer Drugs

Researchers at Rensselaer Polytechnic Institute and Albany Medical Center are working together to develop three-dimensional bioprinting and imaging techniques that will generate and analyze tumor models in the laboratory, with the goal of accelerating the development and optimization of personalized anti-cancer drugs.

Hacking Healthcare and Helping Cancer Patients

Michael Bramson, a 1st year PhD student in the Corr lab, was on one of three winning teams at the 2nd annual Mount Sinai Health Hackathon, and his team was awarded $2500 for their innovative platform Streamline, a web-based service designed to use natural language processing in assisting researchers write clinical trial applications and protocols

Stem Cell Research Projects Displayed

Preliminary results of stem cell research projects sponsored by the Center for Biotechnology and Interdisciplinary Studies (CBIS) were displayed during a poster session and researcher networking lunch held December 2, in the CBIS auditorium and the Senator William H. Hernstadt ’57 and Jerene Yap Hernstadt Gallery.